StockTipsArenaBeta

BUY Caplin Point Laboratories Limited — Ruchit Jain, Motilal Oswal

BUYCaplin Point Laboratories Limited

byRuchit Jain, Motilal OswalHorizon: NA (inferred Swing (≤2wk))2 Sept 2026via NDTV Profit (Live)

Entry₹2,710Inferred
Target₹2,800
Total upside +3.32% (call closed)
Stop loss₹2,640-2.58% risk
Exit₹2,8003 Sept 2026, 10:00 am
Target hit+3.32%0.00%upside left
Follow Ruchit Jain for new calls(28% target hit, 86 closed calls)Get alertsWatch CAPLIPOINT for new buy/sell callsGet alertsSee 116 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 3 Sept 2026
3 supporting0 opposing
Supports the BUY call (3)

Caplin Point Subsidiary Gets Colombian GMP Certification

NewsGoogle News·1 Sept · yesterday

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·2 Sept · yesterday

Caplin Steriles Gets 10 USFDA Observations at Gummidipoondi Facility

NewsGoogle News·22 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.